abstract |
Disclosed herein are compounds having enhanced potency to modulate NMDA receptor activity. The compounds can be used to treat conditions such as depression and related disorders. Also disclosed herein are orally available formulations and other pharmaceutically acceptable delivery forms of the compound, including intravenous formulations. |